Skip to main content
Equibles

BARCLAYS PLC

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 312069 LONDON, X0
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$90,779
+$79,158 QoQ
Shares Held
19,439
+590.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 89 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. XFOR ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in XFOR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $90,779 19,439
2026-03-31 $11,621 2,814
2025-12-31 $230,000 57,500
2025-03-31 $43,679 185,083
2024-12-31 $195,359 266,157
2024-09-30 $185,769 277,682
2024-06-30 $54,416 93,821
2024-03-31 $623,704 448,708
2023-12-31 $444,335 529,601
2023-09-30 $416,526 382,134
2023-06-30 $170,485 87,879
2022-06-30 $96 100
2022-03-31 $13,656 7,804
2021-12-31 $17,871 7,804
2021-09-30 $52,365 9,899
2021-06-30 $106,664 16,410
2021-03-31 $182,919 21,245
2020-12-31 $83,544 12,993
2020-06-30 $1,304 140